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ABSTRACT 
 
 
The Fanconi Anemia pathway is a complex DNA damage response which 
combines translesion synthesis and homologous recombination to repair DNA interstrand 
crosslinks (ICLs). If untreated, these crosslinks will stall replication forks and inhibit 
DNA synthesis. Mutations in any of the fifteen known FA genes, such as Fancd2, result 
in widespread chromosomal instability and the formation of radial chromosome 
structures. The underlying cause of the ICL-induced genomic instability in FA-deficient 
cells is not known.  We considered the hypothesis that proteins of the mismatch repair 
(MMR) pathway contributed to this genomic instability since MMR proteins bind ICLs to  
induce DNA breaks. This MQP presents evidence that Msh2 depletion mitigates the 
formation of radial chromosomes in Fancd2-deficient cells. In addition, we show that 
Msh2 depletion reduces cellular sensitivity to crosslinking agents such as Mitomycin C, 
and suppresses the ATM/ATR checkpoint response. 
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BACKGROUND 
 
Fanconi Anemia 
Fanconi Anemia (FA) is an autosomal recessive disease characterized by 
widespread chromosomal instability. Although the disease is rare and occurs in only 
1/350,000 births, the symptoms are often severe (Moustacchi, 2003). The principle 
features of FA include bone marrow failure, congenital abnormalities, development of 
solid tumors, and susceptibility to leukemia (Alan and D’Andrea, 2011). The average FA 
patient experiences the onset of bone marrow failure at around 7 years of age, but cases 
have been documented in which symptoms occurred earlier, later, or not at all 
(Moustacchi, 2003). Bone marrow failure results in a number of hematological disorders 
since affected individuals are unable to produce a significant amount of blood cells. The 
condition is lethal if untreated, and 90% of FA patients require a bone marrow transplant 
by age 40 (Alan and D’Andrea, 2011). 
Congenital anomalies are a highly prevalent symptom of Fanconi Anemia and are 
often the initial sign of the disease. Anomalies vary greatly between patients but can 
affect the genital, renal, skeletal, auditory, ocular, and central nervous systems (Glanz 
and Fraser, 1982). Since malformations vary so greatly, it is impossible for doctors to 
diagnose the disease based on specific developmental abnormalities. Up to 25% of 
patients do not exhibit any type of congenital abnormality (Glanz and Fraser, 1982). Yet, 
some abnormalities occur much more often than others. Mutations in skin pigmentation 
are the most prevalent, and are observed in 55% of patients. Café au lait spots are the 
most common pigment defect and are typically small and light brown in color (Alter, 
2003).  In addition, 51% of patients suffer from growth retardation which results in a 
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short stature (Alter, 2003). Two hallmark features include abnormalities in the upper 
limbs and male gonads. Upper limb defects usually pertain to the thumb (Figure-1) 
which is malformed or missing in over 40% of patients (Glanz and Fraser, 1982). Other 
common defects include hearing loss, cardiac murmur, mental retardation, and 
microcephaly, a brain development disorder.  
 
Figure 1: Common Thumb Malformations in Fanconi Anemia.  Left photograph, type 
IV thumb deficiency where the thumb is completely disconnected from the skeleton and 
lacks musculature and tendons. Right photograph, type V deficiency where the thumb is 
entirely absent (Kozin, 2008). 
 
 
Perhaps the most striking symptom of Fanconi Anemia is the patient’s disposition 
to tumors and cancers such as leukemia. Children diagnosed with Fanconi Anemia are 
15,000 times more likely to develop acute myelogenous leukemia (AML) than the 
general population (Auerbach and Allen, 1991). Leukemia develops extremely early in 
FA patients and is highly lethal. The average age of death for these children is age 15 
(Auerbach and Allen, 1991). In addition to the risk of developing AML, FA patients are 
also extremely susceptible to the formation of solid tumors. FA patients are 50 times 
more likely than the general population to develop tumors (Rosenberg et al., 2003). By 
age 48, 1 in 3 FA patients are expected to develop a solid tumor (Rosenberg et al., 2003). 
FA patients are also more 700 times more likely to develop squamous cell carcinoma, 
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predominantly in the head and neck (Singh, 2003). FA patients are also extremely 
sensitive to numerous other types of cancer which can eventually lead to their death. 
 
The FA Pathway 
 
Fanconi Anemia is a disease characterized by widespread chromosomal instability 
which results from the improper repair of DNA interstrand crosslinks (ICL) 
(Niedernhofer et al., 2005). ICLs are covalent links that form between the two 
complementary strands of DNA, and can inhibit the formation of replication forks. Since 
the DNA is unable to unwind, both replication and transcription are effectively blocked 
(Moldovan and D’Andrea, 2010). ICLs are highly lethal, and crosslinking agents such as 
Mitomycin C and Cisplatin are commonly used as chemotherapy drugs. Normally, ICLs 
are repaired through a complex response known as the Fanconi Anemia pathway. This 
pathway is able to remove ICLs and reinitiate DNA replication. In FA patients, this 
process is deficient due to mutations in the Fanconi Anemia genes. FA cells are unable to 
correctly clear ICLs which results in the characteristic genomic instability of the disease. 
Often, the DNA becomes broken or fragmented due to improper repair, or large radial 
structures comprising multiple chromosomes are formed (Moldovan and D’Andrea, 
2010). 
Interstrand crosslink repair is a highly complex process that requires multiple 
repair mechanisms including nucleotide excision repair (NER), translesion synthesis 
(TLS), and homologous recombination (HR). While most DNA lesions can be processed 
through multiple damage pathways, ICLs can only be repaired through the function of the 
FA pathway. The pathway currently contains at least fifteen known FA complementation 
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groups which are named FANCA, B, C, D1, D2, E, F, G, I, J, L, M, N, P, and RAD51C 
(Kottemann and Smogorzewska1, 2013). The majority of these genes comprise the FA 
core complex. In response to DNA lesions that occur during replication, the core complex 
monoubiquitinates FANCD2 and FANCI which then localize to sites of DNA damage 
and help initiate the proper response to ICLs (Montes de Oca et al., 2005). 
The most commonly mutated gene in Fanconi Anemia patients is FANCA which 
is responsible for 60% of all cases. It is a member of the core complex along with 
FANCB, C, E, F, G, L, and M (Moldovan and D’Andrea, 2010.) One function of the core 
complex is to monoubiquitinate FANCD2 and FANCI, and initiate the FA pathway 
(Figure-2). FANCD2 is mutated in roughly 5% of FA patients, yet it is used as the 
primary diagnostic tool for the disease. Since FANCD2 is relatively far downstream in 
the FA damage response pathway, mutations in any of the upstream FA proteins will 
prevent its monoubiquitination. This can be clinically measured and used to accurately 
diagnose an FA patient (Moldovan and D’Andrea, 2010). 
As previously mentioned, interstrand crosslinks cannot be repaired by any single 
DNA repair method. When a DNA replication fork encounters a crosslink, helicases are 
unable to separate the two strands of DNA. This stalls the replication fork and repair 
factors are recruited to the lesion. The first response is the induction of a double strand 
break (DSB) (Niedernhofer et al., 2005). Once a DSB is induced on both sides of the 
lesion, the cross-linked base can be removed and bypassed via a TLS mechanism. This 
allows the replication fork to resume its progress along the DNA. Homologous 
recombination is then used restore the DNA to its original structure. FANCD2 is believed 
to hold an important but poorly understood role in mediating HR. Fancd2 has been shown 
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to colocalize with an important HR protein, RAD51, at sights of DNA DSBs (Nakanishi 
et al., 2005). In FA patients, the loss of FANCD2 activity appears to promote non-
homologous end joining (NHEJ). This method does not require a DNA template to repair 
DSBs, but is highly inaccurate and produces frequent mutations. NHEJ is also 
responsible for the formation of radial chromosomes, a hallmark of cells deficient in the 
FA pathway. This has led to the conclusion that one of the most vital roles of the FA 
pathway is to promote HR instead of less accurate mechanisms of repair (Naim and 
Rosselli, 2009). 
 
Figure 2: Repair of ICLs Through the FA Pathway and the Formation of Radial 
Chromosomes. When a replication fork stalls due to an ICL, the FA core complex 
assembles and triggers the monoubiquitination of FANCD2 with the assistance of ATR. 
FANCD2 then localizes to sites of damage and initiates the proper damage response. In 
FA deficient cells, improper repair can result in the formation of Radial chromosomes 
(Niedernhofer, 2005). 
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Once the FANCD2-I complex has been monoubiquitinated, the specific 
mechanism by which it initiates repair is unknown. The complex has been shown to 
colocalize with vital repair proteins such as BRCA2, RAD51, and PCNA (Moldovan and 
D’Andrea, 2010). One theory states that ubiquitinated FANCD2 may recruit other 
molecules which help localize repair factors to sites of DNA damage. It is also possible 
that FANCD2-I may recruit essential factors for specific repair methods such as TLS. 
The FANCD2-I complex may also serve to stabilize repair enzymes on DNA. Whatever 
the mechanism, FANCD2-I localization to ICLs is crucial in initiating the proper repair 
cascade (Moldovan and D’Andrea, 2010). 
ATR is a crucial upstream regulator of the FA pathway and is highly important in 
coordinating the DNA damage response during replication (Moldovan and D’Andrea, 
2010). ATR is an essential component of an S-phase checkpoint that recognizes stalled 
replication forks, and initiates the proper response to promote fork restart and reinitialize 
the cell cycle (Figure-3) (Friedel et al., 2009). It is believed that the ATR checkpoint 
kinase is required to initiate FANCD2 monoubiquitination and promote the FA pathway 
of DNA repair (Andreassen et al., 2004). In ATR-deficient cells, MMC triggers the 
formation of radial chromosomes, indicating that ATR is essential for activating the FA 
pathway in response to crosslinks (Adreassen et al., 2004). FANCD2 has also been 
shown to interact with the checkpoint kinase ATM which arrests replication in response 
to damage. ATM phosphorylates FANCD2 which is required for proper checkpoint 
function (Taniguchi et al., 2002).  
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Figure 3: ATR Checkpoint Kinase Initiates the FA Pathway. In response to a stalled 
replication fork resulting from an ICL, ATR initiates the formation of the FA core 
complex and phosphorylates the FANCD2-I complex. This leads to the 
monoubiquitination of FANCD2-I which allows it to localize to damage and regulate the 
proper repair response (Maldovan and D’Andrea, 2010.) 
 
Msh2 and DNA Mismatch Repair 
 
 DNA mismatch repair (MMR) is responsible for correcting base substitutions, 
insertions, and deletions that occur during DNA replication (Kunkel and Erie, 2005). 
Mutations occur during DNA synthesis due to nucleotide misincorporation which results 
in differences between the two complementary strands of DNA. These mismatches are 
rare and occur in only 1 in 10
10
 base pairs, yet they must be addressed to preserve 
genomic integrity and to prevent future replication issues (Iyer et al., 2006). Unrepaired 
mismatches can result in frame-shift mutations, and defects in the MMR repair system 
have been shown to result in cancer and tumor development (Iyer et al., 2006). 
 The MMR pathway is initiated when MutS homologue protein complexes 
recognize and localize to mispaired bases in the DNA. One vital MutS homologue is 
MSH2 which interacts with MLH1 and other MSH proteins at sights of base mispairs, 
insertions, and deletions (Figure-4) (Kolodner and Marsischky, 1999). Single base-base 
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mismatches are recognized by a MSH2/MSH6 complex known as MutSα. In addition, a 
MSH2/MSH3 complex, MutSβ, is responsible for recognizing insertion and deletion 
mismatches that contain extra nucleotides. Localization of the Mut complex at a 
mismatch results in the recruitment of additional repair proteins and the excision of the 
incorrect nucleotide. The DNA is then resynthesized by DNA polymerase δ (Larrea et al., 
2010). 
 
Figure 4: Msh2 is Involved in the Initiation of the MMR Pathway. MSH2 complexes 
with MSH6 and MSH3 to form MutSα and MutSβ, respectively. These complexes are 
responsible for identifying base mismatches, insertions, and deletions and triggering the 
MMR response (Kolodner and Marsischky, 1999). 
 
 The MMR repair pathway has been shown to interact with the FA pathway and to 
play a role in ATM/ATR mediated checkpoint arrest (Meyers et al., 2003). MMR repair 
proteins, such as MSH2, respond to an ICL and induce DSBs (Zhang et al., 2007). In 
addition, Fancd2 is known to interact with the MMR proteins MSH2 and MLH1 
(Williams et al., 2011). While the importance of this interaction is currently unknown, it 
is possible the MMR plays a significant role in ICL response and the FA pathway. In FA 
deficient cells, it is also possible that MMR repair drives chromosomal instability. MMR 
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proteins could promote error-prone, unproductive ICL processing pathways. In addition, 
MMR repair proteins could induce DSBs which are incorrectly repaired by NHEJ to 
create radial chromosomes. 
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PROJECT PURPOSE 
 
Cells deficient in the Fanconi Anemia pathway are characterized by chromosomal 
instability and the formation of radial chromosomes, yet the mechanism that drives the 
formation of these structures is poorly understood. Mismatch repair proteins such as 
Msh2 have been shown to respond to interstrand crosslinks and may promote inefficient 
and error prone repair methods such as non-homologous end joining. This project aimed 
to address whether Msh2 contributes to the formation of radial chromosomes in a Fancd2 
deficient background. In addition, the project focused on how Msh2 depletion affects cell 
survival and checkpoint activity in response to the crosslinking agent Mitomycin C. 
 15 
METHODS 
 
Cell Culture 
Primary mouse embryonic fibroblasts (MEFs) were prepared from pregnant mice 
at between 13 and 14 days of gestation, and trypsinized with 0.25% trypsin-EDTA for 15 
minutes at 37°C. Medium was added to the tube, and the tissue was minced via pipetting. 
MEF cells were then seeded onto 75cm
2
 flasks with 1 million cells per flask. After 24 
hours, cells were washed with 1X PBS and fed new medium. MEFs were grown in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 15% fetal bovine 
serum (FBS) and 1% penicillin/streptomycin. 
 
Immunoflourescence Microscopy 
MEFs were seeded onto 6 well plates and incubated overnight.  Cells were either 
untreated or treated with Mitomycin C (MMC) (250 nM) for 16 h.  MEFs were then 
washed twice in 1X PBS and fixed with 3% paraformaldehyde/2% sucrose for 10 min at 
RT. After two more washes, cells were permeabilized with 0.5% Triton X-100 in 20 mM 
HEPES for 5 min on ice. Cells were washed thoroughly before incubation with primary 
and secondary antibodies. Incubation was performed with antibodies: γ-H2AX (Upstate 
1:100), 53BP1 (Novus Biologicals, 1:100) or P-ATR/ATM Substrate (Cell Signaling, 
1:100). Secondary antibodies were Rhodamine Red Anti-Mouse IgG (Jackson 
Immunoresearch, 1:200) and Fluorescein (FITC) Anti-Rabbit IgG (Jackson 
Immunoresearch, 1:200).  Cells with greater than 10 foci per cell were scored as positive.  
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Survival Assays 
10,000 MEFs were seeded in 6 well plates. Cells were then treated with MMC for 
1 hour at dosages of 25, 50, 100, and 200 nM, and protected from light. MMC was then 
removed, and the cells were allowed to relax for 5 days. Cells were quantified by hand 
counting under a microscope. 
 
Generation of Mice and PCR Genotyping 
Msh2-deficient mice were obtained from T. Mak, University of Toronto, Toronto 
CA. Fancd2-deficient mice 74 were obtained from M. Grompe, Oregon Health and 
Sciences University, Portland OR. Mice were maintained as double heterozygotes 
(Msh2+/- Fancd2+/-) and were bred to obtain all genotypes studied here. Mice were 
housed in the same room of the IACUC-approved SPF facility at Univ. Mass. Medical 
School, and were bred and used under guidelines formulated by the Univ. of 
Massachusetts Animal Care and Use Committee (IACUC). As previously described 
(Reitmair et al., 1996) 50 ng of DNA was prepared from an embryo’s head or mom’s tail 
and used as a template in PCR to genotype mice. For Fancd2, forward primer MG968 (5 
–TCAGCCTCACATGGAGTT -TAACG -3) and two reverse primers, MG1280 (5 –
GCTACACAGCATTGCCCATA -AAG-3 and MG1008 (5 –
CAGGGATGAAAGGGTCTTAC -GC-3 were used to amplify a mutant band of 459 bp 
or a wild-type band of 303 bp. The reaction conditions were 95C for 2 min; 36 cycles of 
94°C for 25 sec, 58°C for 25 sec, and 72°C for 35 sec; and a final extension at 72°C for 2 
min. For Msh2, forward primer Msh2 COM (5 –AAAGTGCACGTCATTTGGA -3) and 
two reverse primers, Msh2 WT (5 –GCTCACTTAGACGCCATTGT-3 and Msh2 MT (5 
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–GCCTTCTTGACGAGTTCTTC-3 were used to amplify a wild-type band of 174 bp or 
a mutant band of 460 bp. The reaction conditions were 95C for 2 min; 36 cycles of 94C 
for 30sec, 62C for 30 sec, and 72C for 30 sec; and a final extension at 72C for 7 min.  
 
Metaphase Chromosome Spreads 
Stable MEFs were seeded, mock treated, or treated with MMC and incubated in 
media containing 100 ng/ml Colcemid for 1.5 h.  Cells were then harvested by 
trypsinization, incubated in hypotonic solution for 10 min and fixed with fixative solution 
(75% Methanol, 25% Acetic Acid). Cells were then spotted onto slides and stained with 
Giemsa. Slides were then sealed using a second slide and nail polish. Chromosome 
abnormalities (Figure-5) were scored using blind counts (Figure-6) based on standard 
guidelines (Levitt et al., 2007). 
 
Figure 5: Classifications of Chromosomal Aberrations. Aberrations were classified 
into three major subgroups (radials, fragments, and breaks) according to standard 
guidelines.  
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Figure 6: Spread Count Example. Spreads were observed and quantified by eye at 
200x. This spread depicts 7 breaks (B), 3 fragments (F), and 1 radial (R). 
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RESULTS 
 
 
The Fanconi Anemia pathway is a complex DNA damage response which 
combines translesion synthesis and homologous recombination to address interstrand 
crosslinks (ICLs). If untreated, these crosslinks will trigger stalled replication forks that 
inhibit DNA synthesis. Mutations to any of the FA proteins, such as Fancd2, result in 
widespread chromosomal instability and the formation of radial chromosome structures. 
The purpose of this project was to address the role of the DNA mismatch repair pathway 
in promoting error-prone and ineffective repair methods in response to ICLs. This project 
focused on one MMR gene, Msh2, which is important for identifying mismatches, 
insertions, and deletions and initiating mismatch repair. 
To test whether Msh2 contributes to an abnormal DNA damage response, Msh2 
was depleted in Fancd2-null MEFs. This was done by breeding two mice that were 
heterozygous for both Msh2 and Fancd2. The embryos were harvested 13 to 14 days after 
conception, and PCR was used to obtain their genotypes. Three genotypes were used in 
this study (Figure-7): WT (Fancd2+/+, Msh2+/+), Knockout (Fancd2-/-, Msh2+/+), and 
Double knockout (Fancd2-/-, Msh2-/-). 
 
 
 
Figure 7: Genotypes of Mouse Embryonic 
Fibroblasts. The heterozygous parent (Lane-1) 
shows two bands for both Fancd2 and Msh2. 
Homozygous dominant individuals (WT) (Lane-2) 
exhibit a single band for Fancd2, and Msh2 of 300 
bp and 174 bp, respectively. Fancd2 deficient 
individuals (Lane-3) demonstrate bands at 460bp for 
Fancd2 and 174bp for Msh2. Fancd2/Msh2 
recessive individuals (Lane-4) demonstrate bands of 
460 bp for both Fancd2 and Mss2. 
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Mitomycin C (MMC) is a chemotherapeutic drug that is extremely effective at  
producing ICLs.  FA-deficient cells cannot process crosslinks, and demonstrate extreme 
sensitivity to MMC. WT cells are able to respond to ICLs through the FA pathway and 
show reduced genomic stress. To assess how Msh2 depletion affects the Fancd2-deficient 
cells, MEFs were subjected to a survival assay. MEFs were seeded at equal 
concentrations in 6 well plates and subjected four treatments of MMC (25, 50, 100, and 
200 nM) for 1 hour. Cells were then allowed to relax for five days, and surviving cells 
were counted under the microscope (Figure-8). 
 
Figure 8: Msh2 Depletion Reduces Mitomycin C Sensitivity in Fancd2-Deficient 
MEFs. Cells were treated for 1 hour with MMC and allowed to relax for 5 days. Fancd2 
deficient cells demonstrated severe sensitivity relative to WT. When Msh2 was depleted 
in addition to Fancd2, sensitivity was suppressed and cells showed survival rates similar 
to WT. 
 
 
In response to MMC treatment, Fancd2-deficient MEFs (black curve) 
demonstrated severe sensitivity in relation to both the WT and the Fancd2/Msh2-null 
MEFs. At all dosages, Fancd2-deficient cells were highly susceptible to the drug, and 
showed poor survival rates. In contrast, the Fancd2/Msh-null cells (red curve) showed 
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similar survival rates to the WT cells (blue curve). Both of these cell lines demonstrated a 
survival rate 3 times greater than the Fancd2-deficient cells. 
To further investigate this result, chromosome spreads were used to quantify 
chromosomal aberrations (Figure-9). To perform the spreads, cells were treated with 
MMC and incubated in media containing 100 ng/ml Colcemid for 1.5 h. Cells were then 
harvested by trypsinization, incubated in hypotonic solution for 10 min and fixed with 
fixative solution (75% Methanol, 25% Acetic Acid) before being dyed and applied drop-
wise to microscope slides. Chromosomal aberrations were then counted by eye under the 
microscope, and recorded as a percentage based on the number of aberrations per total 
chromosomes. Spreads were counted in a blind manner so that bias would not be 
introduced. 
 
Figure 9: Fancd2/Msh2 Deficient MEFs Show Fewer Radial Chromosomes Than 
Fancd2 Deficient MEFs. After treatment with MMC, both KO and DKO MEFs 
demonstrated a higher frequency of chromosomal aberrations than WT cells.  No 
significant difference was observed between KO and DKO cells in total aberrations. 
When aberrations were classified by type however, Fancd2/Msh2 deficient cells were 
found to have fewer radial chromosomes than Fancd2 deficient cells. 
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The initial set of spread counts (left panel) found that both the Fancd2-null and 
Fancd2/Msh2-null MEFs demonstrated significantly more chromosomal aberrations than 
the wild-type cells. The first set of counts found WT to have 7.2% aberrations, Fancd2 
KO to have 23% aberrations, and Fancd2/Msh2 DKO to have 17.3% aberrations. Unlike 
the survival assay, the Fancd2/Msh2 deficient MEFs did not show a significant difference 
from the Fancd2-null MEFs in terms of total chromosomal aberrations. To further 
investigate, a second round of spread counts was employed. During this count, each 
aberration was classified by type using standard guidelines. Fancd2/Msh2 deficient cells 
were found to have significantly less radial chromosomes with only 1.22% compared to 
4.19% in Fancd2 deficient cells (right panel). Figure-10 shows a comparison of 
aberrations classified by type for knockout and double knock out MEFs. 
 
Figure 10: Prevalence of Chromosomal Aberrations by Type. Fancd2 KO (blue) and 
Fancd2/Msh2 DKO (red) MEFs exhibit similar percentages of breaks and fragments. The 
DKO genotype shows a reduction in the number of radials. 
 
 
The survival assay showed that the presence of Msh2 in Fancd2 deficient MEFs 
severely sensitizes the cells in response to MMC, and that depleting Msh2 in Fancd2-
deficient cells mitigates the sensitivity.  In addition, the spread data showed that the 
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presence of Msh2 helped alleviate the formation of radial chromosomes, although the 
difference in total aberrations was not statistically significant. Given these findings, we 
suspected that the high mortality rates of Fancd2 MEFs could be connected to checkpoint 
response which leads to stalled replication and apoptosis.  
ATM and ATR are kinases responsible for monitoring the FA pathway, and can 
halt replication in response to damage. In addition, ATR is responsible for recognizing 
stalled replication forks. γ-H2AX plays a role in DNA repair and is commonly used as an 
identifier of DSBs.  To determine whether Msh2 reduces the checkpoint response in 
Fancd2-null cells, immunofluorescence microscopy was used to assay the levels of 
ATR/ATM and γ-H2AX in MMC-treated cells (Figure-11). Cells were seeded in 6-well 
plates, incubated overnight, treated with 250 nM MMC for 16 h, and then stained with 
antibodies to both γ-H2AX and ATM/ATR substrates. 
 
Figure 11: MMC Induces a Greater Damage Response in Fancd2-Deficient MEFs 
than in WT or Fancd2/Msh2-Double Deficient MEFs. Fancd2-null MEFs exhibit an 
elevated checkpoint response (ATM/ATR substrate) when treated with MMC. They also 
show elevated p-H2AX levels, indicative of DNA damage. Fancd2/Msh22-null MEFs 
demonstrate similar damage responses to WT cells. Cells containing greater than 10 foci 
were considered positive and are quantified on the right.  
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Phosphorylated H2AX is an indicator of DNA DSBs, and demonstrates the levels 
of DNA damage in each of the cells. p-γH2AX was elevated in Fancd2-null cells, but 
depletion of Msh2 mitigates this effect as p-γH2AX levels were similar to WT in 
Fancd2/Msh2-null cells. An overactive damage response is also indicated by P-
ATM/ATR substrate antibody. This antibody binds to substrates that would typically 
trigger ATM or ATR activity. Fancd2-null cells show a two-fold increase in checkpoint 
activity over WT and Fancd2/Msh2 cells. This is indicative of an increase in stalled 
replication forks and DNA damage. 
  An additional immunofluorescence assay was performed without inducing ICLs 
to view general genomic stress (Figure-12). 53BP1 foci were found to be nearly 2 times 
more prevalent in Fancd2-deficient cells than in WT or Fancd2/Msh2-deficient cells. 
53BP1 is an indicator of DNA lesions resulting from replication. In addition, p-H2AX 
appears to be expressed at slightly higher levels in Fancd2-deficient cells than in the other 
two cell lines. 
 
 
 
Figure 12: Msh2/Fancd2-Deficient MEFs Demonstrate Reduced Genomic Stress. 53BP1 foci are 
indicative of lesions resulting from issues during replication. Fand2-deficient MEFs showed increased 
53BP1 foci when compared to WT. MSH2/Fancd2 deficient cells exhibit foci levels similar to WT cells. 
Fancd2-null cells also show an increase in p-H2AX, a marker of DNA damage. Cells containing greater 
than 10 foci were considered positive and are quantified on the right. 
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DISCUSSION 
 
 
The purpose of this project was to determine whether Msh2 function helps 
contribute to the formation of radial chromosomes in a Fancd2-deficient background. In 
addition, the project focused on how Msh2 deletion affects cell survival and checkpoint 
activity in response to the crosslinking agent MMC. The data obtained provide evidence 
that Msh2 deletion in Fancd2 deficient cells reduces the formation of radial chromosomes 
by a factor of four when compared to Fancd2 null cells. In WT cells, chromosomal 
aberrations are infrequent, and radials are rare. Normally, the FA pathway regulates 
homologous recombination to repair DSBs that occur during interstrand crosslink (ICL) 
repair. These findings suggest that when the FA pathway is deficient, the MMR pathway 
may respond to ICLs and promote ineffective and error-prone methods of repair such as 
NHEJ.  Based on this, we suggest that the FA pathway could serve as an inhibitor of 
MMR. Thus, in the absence of the FA pathway MMR may contribute to chromosomal 
instability in FA-deficient cells. 
 Msh2 deletion in Fancd2 null cells was also shown to desensitize cells to MMC. 
Fancd2-null cells demonstrate significantly lower survival rates than either WT or 
Fancd2/Msh2-null cells. This correlates with the data collected from the spread counts, as 
double knockout cells should be more stable due to reduced NHEJ and radial 
chromosome formation. In addition, checkpoint response was found to be elevated in 
Fancd2 null cells, but reduced with the co-depletion of Msh2. The increased ATM/ATR 
checkpoint response was most likely due to high levels of damage resulting from 
unrestricted MMR activity. This checkpoint response was also a contributing factor 
behind the MMC sensitivity during the survival assay. P-γH2AX levels were also 
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elevated in Fancd2 null cells. This suggests an increase in DSBs which result from 
improper damage response to ICLs. Finally, 53BP1 activity was found to be elevated in 
Fancd2-null cells but was observed as compare to levels in Fancd2/Msh2-deficient cells. 
This finding is consistent with other findings, since 53BP1 is associated with genomic 
stress and instability. 
 Future research should further expand on these findings and continue to elaborate 
upon the results shown here. Previous research has shown that depletion of NHEJ alone 
is not sufficient to prevent the formation of radial chromosomes, and that the genome is 
even more unstable in its absence. On the other hand, our findings reveal the importance 
of the MMR pathway in triggering the formation of radials. Yet the mechanisms behind 
this are not well understood, and Msh2 and Fancd2 are only two components in the MMR 
and FA pathways. To further verify this result and determine the mechanism by which 
the FA and MMR pathways interact, deficiencies in other proteins in each pathway 
should be tested. Other FA genes could be depleted to see if this result remains 
consistent.  
Although the initial experiments in this project focused on counting total 
aberrations/chromosome, this data was inconclusive and the counts were refined to 
quantify aberrations by type. In future experiments, this procedure could be further 
modified to count only radial chromosomes. This will greatly increase the efficiency of 
spread counts and allow for more data to be collected. Ultimately, faster spread counts 
should make it possible to increase the sample size of the radial counts to ensure an 
accurate result. 
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